Advances in relationship between brain-derived neurotrophic factor and depressive disorder

Progress in Biochemistry and Biophysics

Volumn 38, Issue 12, 2011, Pages 1085-1090

  Zhou, Xiao Jiang ^a   Hu, Yuan ^a   Liu, Ping ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

BDNF; Depression; Hippocampus; TrkB

Indexed keywords

EID: 84863289372     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2011.00095     Document Type: Article

References (55)

1. Barde Y A, Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J, 1982, 1(5):549-553
2. Koda M, Kamada T, Hashimoto M, et al. Adenovirus vectormediated ex vivo gene transfer of brain-derived neurotrophic factor to bone marrow stromal cells promotes axonal regeneration after transplantation in completely transected adult rat spinal cord. Eur Spine J, 2007, 16(12):2206-2214 (Pubitemid 350276094)
3. Kim Y K, Lee H P, Won S D, et al. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2007, 31(1):78-85
4. Monteggia L M, Luikart B, Barrot M, et al. Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors. Biol Psychiatry, 2007, 61(2):187-197 (Pubitemid 46072778)
5. Pinnock S B, Herbert J. Brain-derived neurotrophic factor and neurogenesis in the adult rat dentate gyrus: interactions with corticosterone. Eur J Neurosci, 2008, 27(10):2493-2500 (Pubitemid 351781685)
6. Krishnan V, Nestler E J. The molecular neurobiology of depression. Nature, 2008, 455(7215):894-902
7. Castrén E, Voikar V, Rantamäki T, et al. Role of neurotropic factors in depression. Curr Opin Pharmacol, 2007, 7(1):18-21
8. Hajszan T, Dow A, Warner-Schmidt J L, et al. Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression. Biol Psychiatry, 2009, 65(5):392-400
9. Zhang X L, Sullivan J A, Moskal J R, et al. A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus. Neuropharmacology, 2008, 55(7):1238-1250
10. Drevets W C, Price J L, Furey M L Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct, 2008, 213(1-2): 93-118
11. MacMaster F P, Mirza Y, Szeszko P R, et al. Amygdala and hippocampal volumes in familia early onset major depressive disorder. Biol Psychiatry, 2008, 63(4):385-390
12. McKinnon M C, Yucel K, Nazarov A, et al. A meta-analysis examining clinical predietors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci, 2009, 34(1):41-54
13. Duman R S, Monteggia L M. A neurotrophic model for stressrelated mood disorders. Biol Psychiatry, 2006, 59(12):1116-1127
14. Sillaber I, Panhuysen M, Henniger M S, et al. Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology, 2008, 200(4):557-572
15. Larsen M H, Hay-Schmidt A, Ronn L C, et al. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Eur J Pharmacol, 2008, 578(2-3): 114-122 (Pubitemid 350309578)
16. Molteni R, Calabrese F, Chourbaji S, et al. Depression-prone mice with reduced glucocorticoid receptor expression display an altered stress-dependent regulation of brain-derived neurotrophic factor and activity-regulated cytoskeleton-associated protein. J Psychopharmacol, 2010, 24(4):595-603
17. Dunham J S, Deakin J F, Miyajima F, et al. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res, 2009, 43(14):1175-1184
18. Adachi M, Barrot M, Autry A E, et al. Selective loss of brainderived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy. Biol Psychiatry, 2008, 63(7):642-649 (Pubitemid 351329281)
19. Larsen M H, Mikkelsen J D, Hay-Schmidt A, et al. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res, 2010, 44(13):808-816
20. Taliaz D, Stall N, Dar D E, et al. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry, 2010, 15(1):80-92
21. Karege F, Schwald M, Cisse M. Postnatal development profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett, 2002, 328(3):261-264 (Pubitemid 34876661)
22. Shimizu E, Hashimoto K, Okamura N, et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry, 2003, 54(1):70-75 (Pubitemid 36776725)
23. Hu Y, Yu X, Yang F, et al. The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression. J ECT, 2010, 26(2):121-125
24. Monteleone P, Serritella C, Martiadis V, et al. Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord, 2008, 10(1):95-100
25. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions. Psychiatry Clin Neurosci, 2010, 64(4):341-357
26. Tsankova N M, Berton O, Rentha1 W, et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci, 2006, 9(4):519-525
27. Tsai S J, Hong C J, Liou Y J. Effects of BDNF polymorphisms on antidepressant action. Psychiatry Investig, 2010, 7(4):236-242
28. Ibarguen-Vargas Y, Surget A, Vourc'h P, et al. Deficit in BDNF does not increase vulnerability to stress but dampens antidepressantlike effects in the unpredictable chronic mild stress. Behav Brain Res, 2009, 202(2):245-251
29. Brunoni A R, Lopes M, Fregni F. A systematic review and metaanalysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol, 2008, 11(8):1169-1180
30. Aydemir C, Yalcin E S, Aksaray S, et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry, 2006, 30(7):1256-1260 (Pubitemid 44216065)
31. Gervasoni N, Aubry J M, Bondolfi G, et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology, 2005, 51(4):234-238 (Pubitemid 40976406)
32. Piccinni A, Marazziti D, Catena M, et al. Plasma and serum brainderived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord, 2008, 105(1-3): 279-283 (Pubitemid 350245688)
33. Marano C M, Phatak P, Vemulapalli U R, et al. Increased plasma concentration of brain derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J Clin Psychiatry, 2007, 68(4):512-517 (Pubitemid 46663032)
34. Huang T L, Lee C T, Liu Y L. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res, 2008, 42(7):521-525
35. Hu Y, Liao H B, Liu P, et al. Antidepressant-like effects of 3,6'-disinapoyl sucrose on hippocampal neuronal plasticity and neurotrophic signal pathway in chronically mild stressed rats. Neurochemistry International, 2010, 56(3):461-465
36. Hashimoto K. BDNF variant linked to anxiety-related behaviors. Bioessays, 2007, 29(2):116-119 (Pubitemid 46340246)
37. Egan M F, Kojima M, Callicott J H, et al. The BDNF val66met polymorphism affects activity-dependent seceretion of BDNF and human memory and hippocampal function. Cell, 2003, 112(2):257-269 (Pubitemid 36144114)
38. Strauss J, Barr C L, George C J, et al. Brain-derived neurotrophic factor variants are associated with childhood onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry, 2005, 10(9):861-867 (Pubitemid 43080120)
39. Kaufman J, Yang B Z, Douglas-Palumb, et al. Brain-derived neurotrophic factor 5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry, 2006, 59(8):673-680
40. Szeszko P R, Lipsky R, Mentsehel C, et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry, 2005, 10(7):631-636 (Pubitemid 40961733)
41. Bueller J A, Aftab M, Sen S, et al. BDNF Val66 Metallele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry, 2006, 59(9):812-815
42. Gonul A S, Kitis O, Eker M C, et al. Association of the brainderived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. World J Biol Psychiatry, 2011, 12(2):110-118
43. Aguilera M, Arias B, Wichers M, et al. Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population. Psychol Med, 2009, 39(9):1425-1432
44. Wichers M, Kenis G, Jacobs N, et al. The BDNF Val (66) Met × 5-HTTLPR × child adversity interaction and depressive symptoms: an attempt at replication. Am J Med Genet B Neuropsychiatr Genet, 2008, 147 B (1):120-123
45. Chen Z Y, Jing D Q, Bath K G, et al. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science, 2006, 314(5796):140-143 (Pubitemid 44547760)
46. Ribeiro L, Busnello J V, Cantor R M, et al. The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport, 2007, 18(12):1291-1293 (Pubitemid 47075599)
47. Taylor W D, Zuchner S, McQuoid D R, et al. Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression. Am J Geriatr Psychiatry, 2007, 15(10):850-857
48. Xu J, Liu Y, Wang P, et al. Positive association between the brain-derived neurotrophic factor (BDNF) gene and bipolar disorder in the Han Chinese Population. Am J Med Genet B Neuropsychiatr Genet, 2010, 153 B (1):275-279
49. Dwivedi Y, Rizavi H S, Zhang H, et al. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry, 2009, 65(4):319-328
50. Li Y, Luikart B W, Birnbaum S, et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron, 2008, 59(3):399-412
51. Bergami M, Rimondini R, Santi S, et al. Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior. Proc Natl Acad Sci USA, 2008, 105(40):15570-15575
52. Zörner B, Wolfer D P, Brandis D, et al. Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than "depressive". Biol Psychiat, 2003, 54(10):972-982 (Pubitemid 37420083)
53. Karege F, Vaudan G, Schwald M, et al. Neurotrophin levels in post mortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drags. Brain Res Mol Brain Res, 2005, 136(1-2): 29-37 (Pubitemid 40704606)
54. Bayer T A, Schramm M, Feldmann N, et al. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry, 2000, 24(6):881-888
55. Davis M I. Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther, 2008, 118(1):36-57